Ignite Creation Date:
2024-05-05 @ 11:40 AM
Last Modification Date:
2024-10-26 @ 9:11 AM
Study NCT ID:
NCT00101660
Status:
COMPLETED
Last Update Posted:
2012-03-02
First Post:
2005-01-12
Brief Title:
Study of BMS-354825 Dasatinib in Patients With Chronic Myeloid Leukemia Who Are Either Resistant or Intolerant to Imatinib
Sponsor:
Bristol-Myers Squibb
Organization:
Bristol-Myers Squibb
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Philadelphia-Positive Myeloid Leukemia |
| Chronic Myeloid Leukemia |
Keywords:
| Name | View |
|---|---|
| Chronic phase Philadelphia chromosome chronic myeloid leukemia PhCML | View |